N-Ethylhexedrone was patented with the German pharmaceutical corporation Boehringer Ingelheim in 1964 as a potential anorexigenic agent. The patent describes its synthesis together with other derivatives of aminoketone.[1] The public health and fitness pitfalls connected with α-PVP depe